Delivery Order SPE2DB24D1104-SPE2DB25FYAH3

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,237.89, is a Firm Fixed Price Delivery Order to provide 4,567,886,472 units of the prescription drug dextroamphetamine-amphetamine 10 mg capsules. The award has an ultimate completion date of April 14, 2025. This contract is not associated with a set-aside designation. Amerisourcebergen holds a...
This federal contract award, valued at $3,492.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,449.40 firm fixed-price delivery order is for the supply of 4,562,967,887 units of Dextroamphetamine ER 10 mg capsules. The award has an ultimate completion date of December 4, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,047.72, was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA) within the Department of Defense (DoD). The award was made to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of 20 mg capsules of the prescription drug dextroamphetamine-amphetamine, with an ultimate completion date of May 15, 2024. This is a delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,694,053 units of dextroamphetamine-amphetamine 10 mg capsules in lots of 100. The contract has a ceiling value of $1,070.34 and a period of performance through March 26, 2025. It is a delivery order contract with a firm fixed price pricing type. The award is not associated with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.99 firm fixed-price delivery order (SPE2DB20D3103|SPE2DB25FM9H3) is for the supply of 4,567,469,018 Dextroamphetamine-Amphetamine 10 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,153.80 firm-fixed-price delivery order is for 4,567,411,030 units of dextroamphetamine-amphetamine 10 mg tablets, with a completion date of February 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award, valued at $2,373.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,076,029 units of the prescription medication Dextroamphetamine-Amphetamine 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,320.00 firm-fixed-price delivery order is for the supply of 4,564,513,270 units of the prescription drug dextroamphetamine-amphetamine 10 mg capsules. This award is for a period of performance ending on May 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to...
This federal contract award, valued at $1,439.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,956,585 units of the prescription medication Dextroamphetamine-Amphetamine 20 mg capsules, in 100-count bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 17, 2025. This award is not a...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FYAH3
    Delivery Order

This federal contract award, valued at $1,506.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FYAH3) for the supply of 4,568,055,092 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The award does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 (SPE2DX), which provides a comprehensive global pharmaceutical support vehicle through December 2026. This enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/28/25, 11:01 AM